There’s no evidence Merck & Co.’s blockbuster cholesterol drug Vytorin causes cancer, federal regulators said Tuesday. They reviewed reams of data after a patient study last year raised suspicions of a link, weakening sales already hurt by questions about the…

Email this Article
Add to del.icio.us
Add to digg
Add to Facebook




Food and Drug Administration – Cancer – Cholesterol – Health – Ezetimibe/simvastatin

Go here to see the original:
FDA: Review finds no proof Vytorin causes cancer